- Home
- NAUT vs SOPH Comparison
NAUT vs SOPH Comparison
Compare NAUT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | SOPH |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.5M | 367.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAUT | SOPH |
|---|---|---|
| Price | $3.27 | $4.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 372.8K | 93.4K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | $992.86 | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $2.58 |
| 52 Week High | $4.31 | $5.70 |
Technical Indicators
Market Signals| Indicator | NAUT | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.34 | 50.50 |
| Support Level | $1.93 | $4.54 |
| Resistance Level | $4.31 | $4.86 |
| Average True Range (ATR) | 0.42 | 0.30 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 33.92 | 35.31 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.